Articles

Molecular test algorithms for digestive tumours

BJMO - volume 13, issue 1, february 2019

A. Hébrant PhD, Ir , A. Jouret-Mourin MD, PhD, G. Froyen PhD, J. Van der Meulen PhD, M. De Man MD, R. Salgado MD, PhD, M. van den Eynde , N. D’Haene MD, PhD, G. Martens MD, PhD, E. van Cutsem , H.A. Poirel MD, PhD, S. Tejpar MD, PhD, J.L. van Laethem MD, PhD, K. Geboes MD, PhD, P. Pauwels MD, PhD, F. Dedeurwaerdere MD, B. Maes MD, PhD, J. De Grève MD, PhD, J. Vanhuysse , P. Peeters MD, L. Vanacker MD, M. Gomez-Galdon , M. Chintinne MD, PhD, A. Hendlisz MD, PhD, G. de Hertogh , X. Sagaert MD, PhD, M. Peeters MD, PhD, P. Vannuffel , P. Lefesvre MD, PhD, J. Vermeij , M. Simoens , T. Van den Mooter MD, N. van Damme , M. Van den Bulcke PhD

The Belgian Commission of Personalized Medicine has been created to advise the federal government on all matters related to personalised medicine in oncology, including the reimbursement of molecular tests. Here, we propose the Belgian strategy for molecular testing in the digestive tumours within a scientific-based framework. For each tested biomarker, a clinical test level is attached, which is key to establish the relevance of the test and to define the reimbursement. For each digestive tumour type, the different molecular tests are represented as decision trees with its test utility, test level and a brief technical test description.

(BELG J MED ONCOL 2019;13(1):4–10)

Read more

P.06 THE IMPACT OF NETWERK ON THE MULTIDISCIPLINARY TUMOR BOARDS

BJMO - 12, issue 3, february 2018

T. Vandamme MD, W. Lybaert MD, M. Simoens , W. Demey MD, T. Rondou , P. Abrams , C. Mattelaer , B. Op De Beeck , O. D’Archambeau , G. Roeyen , L. De Backer , Marc Peeters , Steering Committee , NET-specialists

Read more

P.07 EXCELLENT SURVIVAL OUTCOMES FOR NET PATIENTS TREATED WITHIN NETWERK, A COLLABORATIVE ENETS CENTER OF EXCELLENCE

BJMO - 12, issue 3, february 2018

T. Vandamme MD, I. Maurissen , W. Lybaert MD, M. Simoens , P. Abrams , A. Driessen MD, PhD, B. Op De Beeck , W. Demey MD, T. Rondou , M. Ulenaers , G. Vanhoutte , M. Peeters MD, PhD, Steering Commitee , NET-specialists

Read more

Highlights of the European Neuroendocrine Tumor Society (ENETS) Congress

BJMO - volume 11, issue 3, may 2017

W. Lybaert MD, M. Simoens , W. Demey MD, F. van Fraeyenhove MD, T. Vandamme MD, L. De Backer , M. Peeters MD, PhD

Barcelona, 8-10 March 2017.

(BELG J MED ONCOL 2017;11(3):129–133)

Read more

P.08 A prospective study on the impact of a NET specific multidisciplinary tumor board on individual treatment plans

BJMO - 2017, issue 3, february 2017

W. Lybaert MD, T. Vandamme MD, M. Simoens , I. Dero MD, W. Demey MD, T. Rondou , A. Cuypers , P. Abrams , C. Mattelaer , A. Driessen MD, PhD, B. Op De Beeck , O. D’Archambeau , G. Roeyen , L. De Backer , M. Peeters MD, PhD, NET specialists NETwerk Steering Committee

Read more

P.14 Launching ‘NETwerk’: diagnosis and treatment of neuroendocrine tumors within a multi-institutional collaboration in the region of Antwerp-Waasland in Belgium

BJMO - 2017, issue 3, february 2017

W. Lybaert MD, T. Vandamme MD, M. Simoens , P. Abrams , W. Demey MD, T. Rondou , M. Ulenaers , G. Vanhoutte , M. Peeters MD, PhD, NET specialists NETwerk Steering Committee

Read more